Repare Therapeutics Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Repare Therapeutics Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2021 to Q3 2024.
  • Repare Therapeutics Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $5.25M, a 17.7% decline year-over-year.
  • Repare Therapeutics Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $24.6M, a 3.18% increase year-over-year.
  • Repare Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2023 was $25.1M, a 27.3% increase from 2022.
  • Repare Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2022 was $19.7M, a 53.5% increase from 2021.
  • Repare Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2021 was $12.8M, a 406% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $24.6M $5.25M -$1.13M -17.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $25.7M $6.52M +$254K +4.05% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $25.5M $6.48M +$413K +6.81% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $25.1M $6.36M +$1.22M +23.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $23.8M $6.38M +$1.32M +26.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $22.5M $6.27M +$1.52M +32% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $21M $6.06M +$1.31M +27.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $19.7M $5.14M +$1.24M +31.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $18.4M $5.05M +$1.36M +36.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $17.1M $4.75M +$1.56M +49.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $15.5M $4.76M +$2.7M +131% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $12.8M $3.9M Oct 1, 2021 Dec 31, 2021 10-K 2023-02-28
Q3 2021 $3.69M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $3.18M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $2.06M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.